Prot #8400-211: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial of IMO-8400 In Patients with Dermatomyositis

Project: Research project

StatusFinished
Effective start/end date3/14/163/14/19

Funding

  • Parexel (Prot #8400-211)
  • Idera Pharmaceuticals, Inc. (Prot #8400-211)